Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification - Concepedia

Concepedia

Publication | Open Access

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

DOI Full Paper Access

246

Citations

41

References

2020

Year

Nicolas R. Barthélemy, Randall J. Bateman, Christophe Hirtz, Philippe Marin, François Bécher, Chihiro Sato, Audrey Gabelle, Sylvain Lehmann

Alzheimer s Research & Therapy

References

	Year	Citations

Page 1